Cargando…

Comparison of Two Chemotherapy Regimens After First-Line Treatment for HER2-Negative Metastatic Gastric Cancer

Aim: Metastatic stage gastric cancer is a disease with a poor prognosis and the likelihood of achieving a cure in these patients is low. Treatment response to subsequent-line treatments is poor. We aimed to investigate the effectiveness of the folinic acid, fluorouracil and irinotecan (FOLFIRI) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urakçı, Zuhat, Ebinç, Senar, Tunç, Sezai, Kalkan, Ziya, Oruç, Zeynep, Küçüköner, Mehmet, Kaplan, Muhammet Ali, Isikdogan, Abdurrahman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256246/ https://www.ncbi.nlm.nih.gov/pubmed/37303360 http://dx.doi.org/10.7759/cureus.38837

Ejemplares similares

Evaluation of Factors Predicting the Effectiveness of Regorafenib in the Treatment of Metastatic Colorectal Cancer
por: Ebinç, Senar, et al.
Publicado: (2022)

Prognostic factors and the prognostic role of inflammation indices in malignant pleural mesothelioma
por: Ebinç, Senar, et al.
Publicado: (2023)

Neoadjuvant Therapy and Factors Influencing Survival in Locally Advanced Non-Small Cell Lung Cancer
por: Ebinç, Senar, et al.
Publicado: (2023)

The importance of serum and pleural fluid level of vascular endothelial growth factor (VEGF) and VEGF fluid/serum ratio in the differential diagnosis of malignant mesothelioma-related pleural effusion
por: Düzköprü, Yakup, et al.
Publicado: (2017)

Testicular Mass: An Initial Sign of Squamous Cell Carcinoma of the Lung
por: Kaplan, Muhammet Ali, et al.
Publicado: (2012)

Germ Cell Tumor Located in Gastrointestinal System: A Report of Two Cases
por: Kucukoner, Mehmet, et al.
Publicado: (2012)

Is there any significance of lung cancer histology to compare the diagnostic accuracies of (18)F-FDG-PET/CT and (99m)Tc-MDP BS for the detection of bone metastases in advanced NSCLC?
por: Inal, Ali, et al.
Publicado: (2014)

Epidemiological and clinical characteristics of malignant melanoma in Southeast Anatolia in Turkey
por: Sula, Bilal, et al.
Publicado: (2016)

Tumor lysis syndrome during radiotherapy for prostate cancer with bone and bone marrow metastases without visceral metastasis
por: Kaplan, Muhammet Ali, et al.
Publicado: (2012)

Treatment of gastrointestinal stromal tumors: A single-center experience
por: Ebinc, Senar, et al.
Publicado: (2021)

Clinical characteristics and treatment outcomes in 132 patients with malignant mesothelioma
por: Abakay, Abdurrahman, et al.
Publicado: (2011)

Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology
por: Mehmet, Kucukoner, et al.
Publicado: (2014)

Can LMWH improve the outcome of patients with inoperable stage III non-small cell lung cancer?
por: Kucukoner, Mehmet, et al.
Publicado: (2012)

Clinical and Laboratory Features of CD5-Negative Chronic Lymphocytic Leukemia
por: Demir, Cengiz, et al.
Publicado: (2017)

Differentiation of Tuberculous Peritonitis from Peritonitis Carcinomatosa without Surgical Intervention
por: Kaya, Muhsin, et al.
Publicado: (2011)

Presence of paroxysmal nocturnal hemoglobinuria in patients with idiopathic portal vein thrombosis: a single-center study
por: DEMiR, Cengiz, et al.
Publicado: (2020)

CNA Landscape of HER2-Negative Breast Cancer in Anthracycline-Based Neoadjuvant Chemotherapy Regimens
por: Ibragimova, M. K., et al.
Publicado: (2023)

The comparison of anthracycline-based and non-anthracycline-based regimens in adjuvant chemotherapy of HER2-positive non-metastatic breast cancers
por: Najafi, Safa, et al.
Publicado: (2018)

Chemotherapy Options beyond the First Line in HER-Negative Metastatic Breast Cancer
por: Lorusso, Vito, et al.
Publicado: (2020)

5-Fluorouracil-induced vasospastic angina
por: Ayyildiz, Orhan, et al.
Publicado: (2005)

Evaluation of outcome and prognostic factors in 739 patients with uterine cervix carcinoma: a single institution experience
por: Teke, Fatma, et al.
Publicado: (2015)

The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients
por: Huang, Weiwei, et al.
Publicado: (2016)

Bevacizumab Added to Neoadjuvant Chemotherapy in HER2-Negative Non-Metastatic Breast Cancer
por: Wan, Guoxing, et al.
Publicado: (2019)

A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2‐negative metastatic breast cancer
por: Chai, Yue, et al.
Publicado: (2023)

Higher Seroprevalence of Hepatitis B Virus Antigen in Patients with Cystic Hydatid Disease than in Patients Referred to Internal Medicine Clinics in Turkey
por: Gültepe, Bilge, et al.
Publicado: (2014)

Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer
por: Hale, J P, et al.
Publicado: (2002)

Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)
por: Blais, Normand, et al.
Publicado: (2014)

Use of eribulin as an earlier-line chemotherapy for patients with HER2-negative metastatic breast cancer
por: Shingaki, Sumito, et al.
Publicado: (2020)

Is Open Science Neoliberal?
por: Uygun Tunç, Duygu, et al.
Publicado: (2022)

Effect of exercise on colorectal cancer prevention and treatment
por: Oruç, Zeynep, et al.
Publicado: (2019)

Erratum: Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)
Publicado: (2014)

Cross-over comparison and new chemotherapy regimens in metastatic pancreatic cancer
por: Kieler, Markus, et al.
Publicado: (2017)

De Novo Osteogenic Sarcoma of Mastoid Bone
por: Işikdogan, Abdurrahman, et al.
Publicado: (2002)

A Meta-Analysis to Assess the Efficacy of HER2-Targeted Treatment Regimens in HER2-Positive Metastatic Colorectal Cancer (mCRC)
por: Chitkara, Akshit, et al.
Publicado: (2023)

Can contemporary trials of chemotherapy for HER2-negative metastatic breast cancer detect overall survival benefit?
por: Kümmel, Sherko, et al.
Publicado: (2018)

Pulmonary Arterial Hypertension in Patients with Primary Sjögren's Syndrome
por: Kobak, Senol, et al.
Publicado: (2014)

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens
por: Moy, Beverly, et al.
Publicado: (2021)

Capecitabine and cisplatin (XP) combination systemic chemotherapy in heavily pre-treated HER2 negative metastatic breast cancer
por: Lee, Jieun, et al.
Publicado: (2017)

Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2-negative metastatic breast cancer: a network meta-analysis
por: Sun, Zhengwu, et al.
Publicado: (2020)

Investigating the discernible and distinct effects of platinum-based chemotherapy regimens for metastatic triple-negative breast cancer on time to progression
por: KHALAF, DANIEL, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_48j4arsf899dcpn9pb7b0eqrcb